Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Type 1 Diabetes: the Pilot 4T Study

Personal glycation factors and calculated HbA1c for diabetes management: Real-world data from the DPV registry

(2021) Yongjin Xu et al.   Diabetes Technology & Therapeutics

Lower HbA1c targets are associated with better metabolic control

(2021) Marlies Van Loocke et al.   EUROPEAN JOURNAL OF PEDIATRICS

The SWEET Project 10-Year Benchmarking in 19 Countries Worldwide Is Associated with Improved HbA1c and Increased Use of Diabetes Technology in Youth with Type 1 Diabetes

(2021) Peter Gerhardsson et al.   Diabetes Technology & Therapeutics

An Evaluation of Two Capillary Sample Collection Kits for Laboratory Measurement of HbA1c

(2021) Roy W. Beck et al.   Diabetes Technology & Therapeutics

‘I was ready for it at the beginning’: Parent experiences with early introduction of continuous glucose monitoring following their child's Type 1 diabetes diagnosis

(2021) Molly L. Tanenbaum et al.   DIABETIC MEDICINE

Improved individual and population-level HbA1c estimation using CGM data and patient characteristics

(2021) Josh Grossman et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Clinically Serious Hypoglycemia Is Rare and Not Associated With Time-in-Range in Youth With New-Onset Type 1 Diabetes

(2021) Ananta Addala et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Population‐level management of type 1 diabetes via continuous glucose monitoring and algorithm‐enabled patient prioritization: Precision health meets population health

(2021) Johannes O. Ferstad et al.   PEDIATRIC DIABETES

HbA1c Levels in Type 1 Diabetes from Early Childhood to Older Adults: A Deeper Dive into the influence of technology and socio-economic status on HbA1c in the T1D Exchange Clinic Registry Findings.

(2020) Kellee M. Miller et al.   Diabetes Technology & Therapeutics

Estimation of Hemoglobin A1c from Continuous Glucose Monitoring Data in Individuals with Type 1 Diabetes: Is Time in Range All We Need?

(2020) Chiara Fabris et al.   Diabetes Technology & Therapeutics

Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes

(2020) Lori M. Laffel et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Uninterrupted continuous glucose monitoring access is associated with a decrease in HbA1c in youth with type 1 diabetes and public insurance

(2020) Ananta Addala et al.   PEDIATRIC DIABETES

Improving Clinical Outcomes in Newly Diagnosed Pediatric Type 1 Diabetes: Teamwork, Targets, Technology, and Tight Control—The 4T Study

(2020) Priya Prahalad et al.   Frontiers in Endocrinology

A Decade of Disparities in Diabetes Technology Use and HbA1c in Pediatric Type 1 Diabetes: A Transatlantic Comparison

(2020) Ananta Addala et al.   DIABETES CARE

The Digital/Virtual Diabetes Clinic: The Future Is Now—Recommendations from an International Panel on Diabetes Digital Technologies Introduction

(2020) Moshe Phillip et al.   Diabetes Technology & Therapeutics

Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes

(2020) Revital Nimri et al.   NATURE MEDICINE

13. Children and Adolescents: Standards of Medical Care in Diabetes—2021

(2020)   DIABETES CARE

Racial and Socioeconomic Disparities in Pediatric Type 1 Diabetes: Time for a Paradigm Shift in Approach

(2020) Terri H. Lipman et al.   DIABETES CARE

State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018

(2019) Nicole C. Foster et al.   Diabetes Technology & Therapeutics

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

(2019) Tadej Battelino et al.   DIABETES CARE

CGM Initiation Soon After Type 1 Diabetes Diagnosis Results in Sustained CGM Use and Wear Time

(2019) Priya Prahalad et al.   DIABETES CARE

Hemoglobin A1c Trajectory in Pediatric Patients with Newly Diagnosed Type 1 Diabetes

(2019) Priya Prahalad et al.   Diabetes Technology & Therapeutics

Exploring Variation in Glycemic Control Across and Within Eight High-Income Countries: A Cross-sectional Analysis of 64,666 Children and Adolescents With Type 1 Diabetes

(2018) Dimitrios Charalampopoulos et al.   DIABETES CARE

Clinically meaningful and lasting HbA1c improvement rarely occurs after 5 years of type 1 diabetes: an argument for early, targeted and aggressive intervention following diagnosis

(2018) Krishnarajah Nirantharakumar et al.   DIABETOLOGIA

Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring

(2018) Richard M. Bergenstal et al.   DIABETES CARE

Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes

(2018) Linda A. DiMeglio et al.   PEDIATRIC DIABETES

Automated integration of continuous glucose monitor data in the electronic health record using consumer technology

(2016) Rajiv B Kumar et al.   JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION

Continued improvement of metabolic control in Swedish pediatric diabetes care

(2016) Ulf Samuelsson et al.   PEDIATRIC DIABETES

Tracking of Metabolic Control from Childhood to Young Adulthood in Type 1 Diabetes

(2014) Sabine E. Hofer et al.   JOURNAL OF PEDIATRICS

Attitudes and Barriers to Exercise in Adults with Type 1 Diabetes (T1DM) and How Best to Address Them: A Qualitative Study

(2014) Nadia Lascar et al.   PLoS One

Most Youth With Type 1 Diabetes in the T1D Exchange Clinic Registry Do Not Meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes Clinical Guidelines

(2013) J. R. Wood et al.   DIABETES CARE

Evidence of a Strong Association Between Frequency of Self-Monitoring of Blood Glucose and Hemoglobin A1c Levels in T1D Exchange Clinic Registry Participants

(2013) K. M. Miller et al.   DIABETES CARE

Lessons from the Hvidoere International Study Group on childhood diabetes: be dogmatic about outcome and flexible in approach

(2013) FJ Cameron et al.   PEDIATRIC DIABETES

Children younger than 7 years with type 1 diabetes are less physically active than healthy controls

(2012) F Sundberg et al.   ACTA PAEDIATRICA

Prevalence of depression among young people with Type 1 diabetes: a systematic review

(2012) B. Johnson et al.   DIABETIC MEDICINE

The Barriers to Physical Activity in Type 1 Diabetes (BAPAD-1) scale: Predictive validity and reliability

(2011) A.S. Brazeau et al.   DIABETES & METABOLISM